Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q1)Sep 30, 2025 | (FY)Jun 30, 2025 | (Q4)Jun 30, 2025 | (Q3)Mar 31, 2025 | (Q2)Dec 31, 2024 | (Q1)Sep 30, 2024 | (FY)Jun 30, 2024 | (Q4)Jun 30, 2024 | (Q3)Mar 31, 2024 | (Q2)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 2.70%1.91B | 8.18%7.08B | 2.29%1.74B | -4.58%1.65B | 8.99%1.82B | 20.04%1.86B | 2.53%6.54B | 16.54%1.7B | 7.27%1.73B | -2.78%1.67B |
| Net interest income | 0.62%1.04B | 3.40%4.06B | 0.56%1.01B | -0.04%991.21M | 4.07%1.02B | 9.33%1.04B | 3.59%3.92B | 9.66%1.01B | 13.12%991.63M | -0.41%975.86M |
| -Total interest income | -0.46%2.31B | 0.51%9.09B | -2.26%2.26B | -1.81%2.24B | 0.87%2.28B | 5.44%2.32B | 16.48%9.04B | 10.51%2.31B | 15.58%2.28B | 15.09%2.26B |
| -Total interest expense | -1.34%1.27B | -1.70%5.03B | -4.44%1.24B | -3.17%1.24B | -1.56%1.26B | 2.50%1.28B | 28.75%5.12B | 11.18%1.3B | 17.55%1.28B | 30.53%1.28B |
| Non interest income | 5.32%863.56M | 15.33%3.02B | 4.80%729.43M | -10.66%660.98M | 15.89%807.37M | 37.00%819.91M | 0.99%2.62B | 28.17%696.05M | 0.32%739.88M | -5.92%696.68M |
| -Total premiums earned | 25.80%192.66M | 70.54%590.4M | 87.84%126.23M | -81.25%34.35M | -14.49%116.87M | 114.47%153.15M | -3.02%346.19M | -26.91%67.2M | 49.99%183.24M | 20.80%136.68M |
| -Fees and commissions | -9.93%182.61M | -17.85%727.78M | -21.91%219.39M | 11.45%231.78M | 17.03%231.18M | 1.64%202.74M | 12.59%885.89M | 50.26%280.92M | 3.07%207.97M | 0.42%197.54M |
| -Including:Fees and commission income | -8.83%213.85M | -14.17%846.46M | -21.15%244.96M | 13.24%262.79M | 19.15%261.45M | 4.69%234.57M | 14.44%986.23M | 48.62%310.68M | 7.40%232.07M | 1.52%219.42M |
| -Including:Fees and commission expense | -1.83%31.24M | 18.28%118.67M | -14.04%25.58M | 28.65%31.01M | 38.33%30.26M | 29.37%31.82M | 33.82%100.33M | 34.73%29.75M | 68.46%24.11M | 12.68%21.88M |
| -Dividend income | 101.48%31.07M | 11.98%81.06M | -16.46%10.44M | 58.42%29.12M | 56.06%26.08M | -37.81%15.42M | -21.65%72.39M | -53.99%12.5M | -31.47%18.38M | 14.54%16.71M |
| -Gain loss on sale of securities | 3.82%431.78M | 15.81%1.41B | 9.52%367.2M | -12.21%292.46M | 7.44%333.39M | 74.85%415.89M | 8.33%1.22B | 46.48%335.29M | 8.88%333.14M | -13.52%310.3M |
| -Net reversal of impairment loss of financial instruments | 230.94%546K | -136.12%-389K | -354.39%-259K | -38.39%589K | -716.22%-302K | -293.95%-417K | 663.83%1.08M | 18.57%-57K | 677.24%956K | -121.02%-37K |
| -Total other operating income | -75.06%30.46M | 108.35%282.19M | 202.03%24.83M | 420.95%91.49M | -58.89%43.71M | 147.32%122.15M | -0.04%135.44M | 118.07%8.22M | -135.95%-28.51M | -3.63%106.33M |
| Credit losses provision | 380.62%37.49M | -235.56%-383.6M | 110.18%3.17M | -1,399.37%-399.18M | 182.82%4.61M | 115.30%7.8M | -199.61%-114.32M | -329.15%-31.14M | -170.18%-26.62M | -121.37%-5.56M |
| Operating expense | -6.80%614.57M | 0.22%2.51B | -17.35%561.62M | 0.97%634.01M | 12.71%659.41M | 6.94%659.41M | 4.36%2.51B | 8.17%679.51M | 3.42%627.9M | -0.50%585.04M |
| Staff costs | -1.98%372.83M | -1.14%1.45B | -17.79%322.87M | 3.44%379.38M | 4.66%368.23M | 6.79%380.35M | 7.06%1.47B | 4.10%392.74M | 5.90%366.77M | 9.17%351.85M |
| Selling and administrative expenses | -20.03%97.1M | 12.97%473.19M | -8.11%113.14M | -1.91%105.49M | 51.51%133.15M | 21.00%121.41M | -0.98%418.88M | 21.06%123.12M | 2.69%107.54M | -21.56%87.88M |
| -Selling and marketing expense | -33.02%42.7M | 20.71%240.22M | 0.16%57.42M | -4.64%46.07M | 72.55%72.98M | 24.82%63.75M | -6.66%199.01M | 20.95%57.33M | -10.53%48.31M | -27.14%42.3M |
| -General and administrative expense | -5.65%54.4M | 5.96%232.97M | -15.30%55.72M | 0.32%59.42M | 32.00%60.17M | 17.04%57.66M | 4.79%219.87M | 21.16%65.79M | 16.75%59.23M | -15.56%45.59M |
| Depreciation and amortization | -8.70%50.18M | -9.26%209.31M | -20.73%45.02M | -12.37%53.65M | 4.23%55.68M | -7.22%54.96M | 0.62%230.68M | -0.12%56.8M | 9.00%61.23M | -7.27%53.42M |
| -Depreciation | -12.45%32.22M | -12.53%137.95M | -22.42%29.26M | -11.89%34.86M | -6.14%37.04M | -10.21%36.8M | -5.70%157.72M | -6.30%37.71M | -3.20%39.56M | -7.11%39.47M |
| -Amortization | -1.11%17.96M | -2.19%71.36M | -17.38%15.77M | -13.24%18.8M | 33.56%18.64M | -0.51%18.16M | 17.69%72.96M | 14.84%19.09M | 41.57%21.67M | -7.71%13.95M |
| Rent and land expenses | 2.84%3.98M | -5.22%15.95M | -4.31%4.15M | -12.09%3.56M | 2.32%4.36M | -7.19%3.87M | 10.13%16.83M | 11.51%4.34M | 0.80%4.05M | 10.82%4.26M |
| Insurance and claims | -33.15%8.64M | -17.77%44.24M | -88.98%1.46M | 14.22%16.6M | -3.01%13.26M | 4.29%12.93M | 18.60%53.8M | 2.28%13.2M | 20.84%14.53M | 25.56%13.67M |
| Other operating expenses | -4.72%81.85M | -0.13%320.93M | -16.06%74.98M | 2.11%75.33M | 14.58%84.73M | 1.89%85.9M | 0.25%321.35M | 18.18%89.32M | -12.02%73.77M | -9.05%73.95M |
| Income from associates and other participating interests | -15.50%332.86M | -8.77%1.54B | -9.34%390.45M | -16.61%344.21M | -11.87%414.22M | 4.33%393.92M | 23.54%1.69B | 17.87%430.69M | 20.94%412.75M | 21.49%470.02M |
| Special income (charges) | -52.38%60K | -4,658.72%-398.48M | -101.66%-115K | -1,374,200.00%-398.49M | 0 | -62.16%126K | 2,158.66%8.74M | 17,175.00%6.91M | 2,800.00%29K | 73,550.00%1.47M |
| Less:Other special charges | 52.38%-60K | 4,658.72%398.48M | 101.66%115K | 1,374,200.00%398.49M | ---- | 62.16%-126K | -2,158.66%-8.74M | -17,175.00%-6.91M | -2,800.00%-29K | -73,550.00%-1.47M |
| Other non-operating income (expenses) | -44.58%2.37M | 1,918.61%13.09M | 70.38%-4.44M | 39.44%11.01M | 47.66%2.24M | -11.72%4.28M | -103.38%-720K | -298.79%-14.98M | 5.96%7.9M | -74.81%1.52M |
| Income before tax | 0.14%1.59B | 4.40%6.1B | 5.82%1.56B | -11.40%1.37B | 0.60%1.58B | 16.42%1.59B | 11.32%5.85B | 23.88%1.48B | 17.69%1.55B | 4.46%1.57B |
| Income tax | 5.07%334.27M | 16.84%1.24B | 7.71%295.55M | -5.59%309.06M | -2.89%311.41M | 28.12%318.13M | 15.15%1.06B | 38.03%274.4M | 50.91%327.36M | 13.27%320.69M |
| Net income | -1.10%1.26B | 1.65%4.87B | 5.38%1.27B | -12.96%1.07B | 1.49%1.26B | 13.81%1.27B | 10.50%4.79B | 21.05%1.2B | 11.14%1.22B | 2.41%1.25B |
| Net income continuous operations | -1.10%1.26B | 1.65%4.87B | 5.38%1.27B | -12.96%1.07B | 1.49%1.26B | 13.81%1.27B | 10.50%4.79B | 21.05%1.2B | 11.14%1.22B | 2.41%1.25B |
| Noncontrolling interests | -1.80%413.9M | 1.37%1.61B | 4.39%414.43M | -13.46%350.91M | 2.67%424.55M | 12.85%421.47M | 9.53%1.59B | 20.32%397.02M | 11.12%405.49M | 2.20%413.53M |
| Net income attributable to the company | -0.75%841.32M | 1.78%3.25B | 5.88%853.45M | -12.71%714.12M | 0.91%839.46M | 14.30%847.67M | 11.00%3.2B | 21.41%806.09M | 11.15%818.07M | 2.51%831.87M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | -0.75%841.32M | 1.78%3.25B | 5.88%853.45M | -12.71%714.12M | 0.91%839.46M | 14.30%847.67M | 11.00%3.2B | 21.41%806.09M | 11.15%818.07M | 2.51%831.87M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | -0.67%0.742 | 1.77%2.869 | 5.77%0.752 | -12.62%0.63 | 0.95%0.74 | 14.22%0.747 | 10.98%2.819 | 21.54%0.711 | 11.09%0.721 | 2.37%0.733 |
| Diluted earnings per share | -0.67%0.742 | 1.77%2.869 | 5.77%0.752 | -12.62%0.63 | 0.95%0.74 | 14.22%0.747 | 10.98%2.819 | 21.54%0.711 | 11.09%0.721 | 2.37%0.733 |
| Dividend per share | 0 | 12.00%0.56 | 0 | 11.11%0.2 | 12.50%0.36 | 0 | 4.17%0.5 | 0 | 5.88%0.18 | 3.23%0.32 |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.